Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View On December 15, Bank of America raised its price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $700 from $650 and kept a Buy rating on the shares. The firm said it was updating price targets across its Life Sciences & Diagnostic Tools coverage. According to the analyst, current headwinds are expected to ease, wit ...